脊髄刺激療法市場規模、シェア、成長分析、適応症別、製品別、エンドユーザー別、地域別 - 産業予測、2024～2031年

脊髄刺激療法の世界市場規模は、2022年に29億米ドルと評価され、2023年の31億3,000万米ドルから2031年には57億米ドルに成長し、予測期間（2024～2031年）のCAGRは7.8％で成長する見通しです。

脊髄刺激装置（SCS）は背柱刺激装置としても知られ、慢性疼痛管理に効果的な神経調節装置として世界市場で大きな支持を得ています。この植え込み型器具は痛みのシグナルを遮断し、脊髄、背中、手足の痛みに苦しむ人々を、特に従来の薬物療法や治療がうまくいかない場合に支援します。最近の技術の進歩に加え、SCS手術に関する新しい法律ガイドラインや低侵襲治療への嗜好の高まりが、市場の成長をさらに促進しています。また、座りっぱなしのライフスタイルに起因する慢性疼痛の増加も、神経刺激療法の需要急増に寄与しています。このような要因が組み合わさることで、SCS市場は近い将来、飛躍的な成長を遂げ、より大きな機会に恵まれることになると思われます。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2023年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

脊髄刺激療法市場規模：適応症別およびCAGR（2024～2031年）

• 市場概要
• 脊椎手術不成功症候群
• 複雑性局所疼痛症候群
• 変性椎間板疾患
• その他

脊髄刺激療法市場規模：製品別およびCAGR（2024～2031年）

• 市場概要
• 充電式デバイス
• 非充電式デバイス

脊髄刺激療法市場規模：エンドユーザー別およびCAGR（2024～2031年）

• 市場概要
• 病院
• 外来手術センター
• その他

脊髄刺激療法市場規模およびCAGR（2024～2031年）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2021～2023年）

主要企業プロファイル

• Medtronic plc（Ireland）
• Boston Scientific Corporation（USA）
• Abbott Laboratories（USA）
• Nevro Corp.（USA）
• Stimwave Technologies, Inc.（USA）
• Saluda Medical Pty Ltd.（Australia）
• Synapse Biomedical Inc.（USA）
• Cirtec Medical（USA）
• Nalu Medical, Inc.（USA）
• Beijing PINS Medical Co., Ltd.（China）
• Gimer Medical（China）
• BIOTRONIK SE & Co. KG（Germany）
• St. Jude Medical, Inc.（acquired by Abbott）（USA）
• NeuroSigma, Inc.（USA）
• Greatbatch, Inc.（USA）
• Curonix LLC（USA）
• Teliatry, Inc.（USA）
• Spinal Modulation（USA）
• NevroSpin（USA）
• Axonics Modulation Technologies, Inc.（USA）

結論と推奨事項

Global Spinal Cord Stimulation Market size was valued at USD 2.9 billion in 2022 and is poised to grow from USD 3.13 billion in 2023 to USD 5.7 billion by 2031, growing at a CAGR of 7.8% during the forecast period (2024-2031).

The spinal cord stimulator (SCS), also known as the dorsal column stimulator, is gaining significant traction in the global market as an effective neuromodulation device for chronic pain management. This implanted tool disrupts pain signals, aiding individuals suffering from spinal, back, or limb pain, particularly when traditional medications and therapies fail. Recent advancements in technology, alongside new legislative guidelines for SCS operations and the rising preference for minimally invasive treatments, have further fueled market growth. The increasing prevalence of chronic pain, largely attributable to sedentary lifestyles, is also contributing to the surging demand for neurostimulation therapies. This combination of factors positions the SCS market for expansive growth and greater opportunities in the near future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Spinal Cord Stimulation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Spinal Cord Stimulation Market Segmental Analysis

Global Spinal Cord Stimulation Market is segmented by indication, product, end user and region. Based on indication, the market is segmented into failed back surgery syndrome, complex regional pain syndrome, degenerative disc disease and others. Based on product, the market is segmented into rechargeable devices and non-rechargeable devices. Based on end user, the market is segmented into hospitals, ambulatory surgical centers and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Spinal Cord Stimulation Market

The Global Spinal Cord Stimulation market is being propelled forward by continuous technological advancements and supportive government recommendations. Manufacturers are focusing on research to produce smaller spinal cord stimulators, exemplified by Stimwave LCC's Freedom SCS system, which is about 5% smaller than current Implantable Pulse Generators (IPGs). This reduction in size, along with improvements in impulse generation, significantly contributes to the market's growth. Furthermore, various government associations are developing guidelines for spinal cord stimulation therapy to treat chronic pain and other conditions. Notably, the National Institute for Health and Care Excellence has provided recommendations for the Senza SCS system, which delivers HF10 therapy for neuropathic pain, fostering increased market activity through these favorable endorsements.

Restraints in the Global Spinal Cord Stimulation Market

The Global Spinal Cord Stimulation market faces several significant restraints that impede its growth. One of the primary challenges is the high cost associated with spinal cord stimulator implantation, which ranges from $21,000 to $58,000. The financial burden varies depending on the patient's insurance status, whether private or public, or if they are paying out-of-pocket. Moreover, ongoing maintenance expenses-including hardware costs, salaries of healthcare providers, pulse generator replacements, and hospitalization fees-add to the overall financial strain on patients. Additionally, the limited availability of healthcare equipment in remote areas restricts access to treatment, forcing local populations to depend on larger towns for essential medical services.

Market Trends of the Global Spinal Cord Stimulation Market

The Global Spinal Cord Stimulation (SCS) market is experiencing a significant upward trend due to increasing government initiatives aimed at reducing opioid dependence. With rising concerns about opioid misuse, alternative therapies that provide effective pain management without the addictive risks of opioids are gaining traction. This shift has prompted manufacturers such as Medtronic, Abbott, and Boston Scientific to expedite the development and approval of innovative SCS devices, evidenced by over 200 submissions to the FDA for rapid approval. As awareness and demand for these non-opioid solutions continue to rise, the SCS market is poised for substantial growth, presenting lucrative opportunities for stakeholders.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Spinal Cord Stimulation Market Size by Indication & CAGR (2024-2031)

• Market Overview
• Failed Back Surgery Syndrome
• Complex Regional Pain Syndrome
• Degenerative Disc Disease
• Others

Global Spinal Cord Stimulation Market Size by Product & CAGR (2024-2031)

• Market Overview
• Rechargeable Devices
• Non-Rechargeable Devices

Global Spinal Cord Stimulation Market Size by End User & CAGR (2024-2031)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Others

Global Spinal Cord Stimulation Market Size & CAGR (2024-2031)

• North America (Indication, Product, End User)
  • US
  • Canada
• Europe (Indication, Product, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Indication, Product, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Indication, Product, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Indication, Product, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nevro Corp. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stimwave Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Saluda Medical Pty Ltd. (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synapse Biomedical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cirtec Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nalu Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beijing PINS Medical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gimer Medical (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIOTRONIK SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• St. Jude Medical, Inc. (acquired by Abbott) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroSigma, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Greatbatch, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Curonix LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teliatry, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Spinal Modulation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NevroSpin (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Axonics Modulation Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations